These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 15001829)

  • 21. Treatment of oesophageal bile reflux in children: the results of a prospective study with omeprazole.
    Orel R; Brecelj J; Homan M; Heuschkel R
    J Pediatr Gastroenterol Nutr; 2006 Apr; 42(4):376-83. PubMed ID: 16641575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seven-year follow-up of a randomized clinical trial comparing proton-pump inhibition with surgical therapy for reflux oesophagitis.
    Lundell L; Miettinen P; Myrvold HE; Hatlebakk JG; Wallin L; Malm A; Sutherland I; Walan A;
    Br J Surg; 2007 Feb; 94(2):198-203. PubMed ID: 17256807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An overview of the pharmacology, efficacy, safety and cost-effectiveness of lansoprazole.
    Bown RL
    Int J Clin Pract; 2002 Mar; 56(2):132-9. PubMed ID: 11926700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastro-oesophageal reflux in children.
    Taminiau JA
    Scand J Gastroenterol Suppl; 1997; 223():18-20. PubMed ID: 9200301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-dose proton-pump inhibitors as a diagnostic test of gastro-oesophageal reflux disease in endoscopic-negative patients.
    Juul-Hansen P; Rydning A; Jacobsen CD; Hansen T
    Scand J Gastroenterol; 2001 Aug; 36(8):806-10. PubMed ID: 11495074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review article: long-term use of proton pump inhibitors in GORD--help or hindrance?
    Tytgat GN
    Aliment Pharmacol Ther; 2001 Sep; 15 Suppl 2():6-9. PubMed ID: 11556874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of long-term treatment with proton pump inhibitors in gastro-oesophageal reflux disease on the histological findings in the lower oesophagus.
    Stolte M; Vieth M; Schmitz JM; Alexandridis T; Seifert E
    Scand J Gastroenterol; 2000 Nov; 35(11):1125-30. PubMed ID: 11145281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of drug therapy in the treatment of gastro-oesophageal reflux disorder in children.
    Cucchiara S; Franco MT; Terrin G; Spadaro R; di Nardo G; Iula V
    Paediatr Drugs; 2000; 2(4):263-72. PubMed ID: 10946415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis and treatment of gastro-oesophageal reflux disease in infants and children.
    Vandenplas Y; Hegar B
    J Gastroenterol Hepatol; 2000 Jun; 15(6):593-603. PubMed ID: 10921411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the effects of esomeprazole and fundoplication on airway responsiveness in patients with gastro-oesophageal reflux disease.
    Kiljander T; Rantanen T; Kellokumpu I; Kööbi T; Lammi L; Nieminen M; Poussa T; Ranta A; Saarelainen S; Salminen P
    Clin Respir J; 2013 Jul; 7(3):281-7. PubMed ID: 23006321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current pharmacological management of gastro-esophageal reflux in children: an evidence-based systematic review.
    Tighe MP; Afzal NA; Bevan A; Beattie RM
    Paediatr Drugs; 2009; 11(3):185-202. PubMed ID: 19445547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of proton-pump inhibitor therapy in patients with gastroesophageal reflux disease and difficult-to-control asthma.
    Goh KL; Wong CH
    Expert Opin Pharmacother; 2006 Oct; 7(15):2015-7. PubMed ID: 17020428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lansoprazole in children: pharmacokinetics and efficacy in reflux oesophagitis.
    Faure C; Michaud L; Shaghaghi EK; Popon M; Laurence M; Mougenot JF; Hankard R; Navarro J; Jacoz-Aigrain E
    Aliment Pharmacol Ther; 2001 Sep; 15(9):1397-402. PubMed ID: 11552911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term management of gastro-oesophageal reflux disease with omeprazole or open antireflux surgery: results of a prospective, randomized clinical trial. The Nordic GORD Study Group.
    Lundell L; Miettinen P; Myrvold HE; Pedersen SA; Thor K; Lamm M; Blomqvist A; Hatlebakk JG; Janatuinen E; Levander K; Nyström P; Wiklund I
    Eur J Gastroenterol Hepatol; 2000 Aug; 12(8):879-87. PubMed ID: 10958215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacotherapy of gastro-oesophageal reflux disease in children: focus on safety.
    Vandenplas Y; Badriul H; Salvatore S; Hauser B
    Expert Opin Drug Saf; 2002 Nov; 1(4):355-64. PubMed ID: 12904135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastro-oesophageal reflux: clinical profiles and outcome.
    Lee WS; Beattie RM; Meadows N; Walker-Smith JA
    J Paediatr Child Health; 1999 Dec; 35(6):568-71. PubMed ID: 10634985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD.
    Cheng E; Zhang X; Huo X; Yu C; Zhang Q; Wang DH; Spechler SJ; Souza RF
    Gut; 2013 Jun; 62(6):824-32. PubMed ID: 22580413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastro-oesophageal reflux disease.
    de Carle DJ
    Med J Aust; 1998 Nov; 169(10):549-54. PubMed ID: 9861914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rabeprazole plus domperidone: the answer for gastro-oesophageal reflux disease.
    Shahani S; Sawant P; Dabholkar P
    J Indian Med Assoc; 2008 Apr; 106(4):264, 266, 268. PubMed ID: 18828350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gastro-oesophageal reflux and chronic respiratory disease in infants and children: treatment with cisapride.
    Olafsdottir E
    Scand J Gastroenterol Suppl; 1995; 211():32-4. PubMed ID: 8545628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.